Dr. Elena Bitrian, MD

Dr. Bitrian practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Bitrian's NPI, 1528356110, was assigned on July 16, 2011. Dr. Bitrian graduated from Universidad de Barcelona Faculty of Medicine in 2003. Dr. Bitrian holds Florida license ME142745.

Dr. Bitrian's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Bitrian's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Dr. Bitrian is also affiliated with Baptist Health Doctors Hospital. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Bitrian to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bitrian practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Bitrian's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Bitrian is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Bitrian's licenses on file in 3 states: Florida, California and Minnesota.

Dmand AI lists cataract, cataract surgery with lens implant, glaucoma, glaucoma surgery, inflammation of iris, secondary membranaous cataract surgery and vision problems among the conditions Dr. Bitrian treats.

CMS data shows 801 Medicare services from Dr. Bitrian across 10 procedure codes in 2024, for 272 Medicare patients. Medicare paid $75,854 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 272 Medicare patients who saw Dr. Bitrian in 2024. The largest group is 65 to 74, with 118 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bitrian's median patient age at 74, with 58% women.

In 2024, Dr. Bitrian wrote 2,508 Medicare Part D claims for 479 patients. 60% of them were for generic drugs. CMS names the drug for 2,419 of them, across 22 drugs with 11 or more claims each, at $146,864 in total drug cost. In 2023, CMS named 2,011 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Bitrian for performance year 2024, reported as part of a group. Dr. Bitrian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 108 procedures of cataract surgery by Dr. Bitrian, more than 75% of the clinicians it reports for that procedure.

Dmand AI links 27 papers to Dr. Bitrian, published from 2012 to 2025. 2024 was the busiest year, with 10. The most frequent topics are Glaucoma, Intraocular Pressure and Anti-Bacterial Agents. Dr. Bitrian has published most often in Am J Ophthalmol Case Rep. Dr. Bitrian's most frequent co-authors are Alana Lee Grajewski, MD, Ta Chen Peter Chang, MD and Elizabeth Ann Hodapp, MD.

CMS Open Payments shows 56 general payments to Dr. Bitrian from 10 drug and device companies from 2019 to 2025. Consulting fees make up the largest share, 48% of the total. Bausch & Lomb Americas Inc. paid the most, $6,000.

Dr. Bitrian graduated from Universidad de Barcelona Faculty of Medicine in 2003.

Dr. Bitrian is in network with 12 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.